Register Now

12pm - 3pm, November 22, 2019
Location: University City Science Center, Delaware River Room, 3rd floor, Philadelphia

CAR-T therapy development has achieved big success over the past years with the regulatory approval by FDA for blood cancer treatment. In this workshop, experts from industry will be assembled to discuss the development and implementation of this therapy. Their topics will cover several key aspects of CAR-T industry chain, from discovery, manufacture to commercialization.  

Speaker 1: Allison Montalvo, Executive Director, Head of Project Management and Clinical Supply, Tmunity Therapeutics
Topic: CAR-T CMC management: how to streamline drug development, manufacturing and logistics (Tentative)
Speaker 2Fang Chen, Senior Research Investigator, Center for Cellular Immunotherapies (CCI), University of Pennsylvania
Topic: Engineered T Cell Therapies From a Drug Development Viewpoint
Speaker 3Teng Peng, Application Support Manager, ACROBiosystems
Topic: The Applications of ACROBiosystem’s Products in CAR-T Cell Therapeutics
Speaker 4: Levi Gray-Rupp, Associate Director, CAR-T/iPSC, Janssen
Topic: Leveraging synthetic biology to enhance CAR-T safety and efficacy